Sign in

CIK 0002020932

  • Non-accelerated filer
  • Emerging growth company

AgomAb Therapeutics NV

Sign in to watch
Ticker
AGMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Belgium
Entity type
Other
Phone
+32 33023530
Business address
POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600